Increased Risk of Secondary Cancers with CML - Chronic myeloid leukemia
Patients with CML may experience a higher incidence of second hematologic malignancies compared with the general population. The most common secondary malignancies in CML patients under treatment were cancers of the skin, prostate, colon, lung and non Hodgkin's lymphoma.
ARTICLES
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia
May 23, 2022, AJH
Second Cancers After Chronic Myeloid Leukemia
June 9, 2020, American Cancer Society
Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors
July 2019, Leukemia Research
Increased Incidence of Second Malignancies in Patients With Chronic Myeloid Leukemia
May 21, 2019, Oncology Nurse Advisor
Patients with Chronic Myeloid Leukemia at Increased Risk of Secondary Cancers
March 13, 2018, Cancer Therapy Advisor
An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States
February 12, 2018, PeerJ
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia
September 2017, Haematologica
Non-Hodgkin Lymphoma Elevated in Imatinib-Treated CML Survivors
March 16, 2016, Cancer Network
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
February 26, 2016, Leukemia
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era
March 27, 2015, BJHaem
Secondary Malignancies in CML Patients – Data From the German CML Study IV
November 16, 2012, Journal Blood
Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study.
September 21, 2010, Europe PMC
Prevalence of Prior Prostate Cancer in Patients Diagnosed with Chronic Myelogenous Leukemia
2006, Journal Blood
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia
May 23, 2022, AJH
Second Cancers After Chronic Myeloid Leukemia
June 9, 2020, American Cancer Society
Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors
July 2019, Leukemia Research
Increased Incidence of Second Malignancies in Patients With Chronic Myeloid Leukemia
May 21, 2019, Oncology Nurse Advisor
Patients with Chronic Myeloid Leukemia at Increased Risk of Secondary Cancers
March 13, 2018, Cancer Therapy Advisor
An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States
February 12, 2018, PeerJ
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia
September 2017, Haematologica
Non-Hodgkin Lymphoma Elevated in Imatinib-Treated CML Survivors
March 16, 2016, Cancer Network
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
February 26, 2016, Leukemia
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era
March 27, 2015, BJHaem
Secondary Malignancies in CML Patients – Data From the German CML Study IV
November 16, 2012, Journal Blood
Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study.
September 21, 2010, Europe PMC
Prevalence of Prior Prostate Cancer in Patients Diagnosed with Chronic Myelogenous Leukemia
2006, Journal Blood
Modes of access to the website
1 - Public access (strongly recommended)
On several occasions, the CML patient called CMLer will need a password to access several modules of the website.
(No registration required - Anonymous access)
1 - Public access (strongly recommended)
On several occasions, the CML patient called CMLer will need a password to access several modules of the website.
(No registration required - Anonymous access)
2 - Reserved access to CMLeukemia private group
On other occasions, the more experienced patients will need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
(Member password required and registration required).
On other occasions, the more experienced patients will need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
(Member password required and registration required).